Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1 - PubMed (original) (raw)
Comparative Study
. 1999 Jan-Feb;19(1A):579-87.
Affiliations
- PMID: 10226602
Comparative Study
Modulation of wild-type p53 activity by mutant p53 R273H depends on the p53 responsive element (p53RE). A comparative study between the p53REs of the MDM2, WAFI/Cip1 and Bax genes in the lung cancer environment. WAFI/Cip1 = WAF1/Cip1
P V Zacharatos et al. Anticancer Res. 1999 Jan-Feb.
Abstract
Wild-type (wt) p53 is a tumor-suppressor protein which acts via transcriptional and transcriptional-independent mechanisms. The transcriptional function of p53 is mediated by specific responsive elements (REs). The MDM2, WAF1/Cip1 and Bax genes possess p53REs and their activation by wt p53 induces cell cycle progression, arrest and programmed cell death (apoptosis), respectively. Mutations of the p53 gene are detected in more than 50% of the human malignant tumors. p53 mutants seem to have a more stable conformation and are suggested to exert dominant-negative inhibition of wt p53 in cells containing both wt and mutant (mt) alleles. However, recent studies show that certain mt p53 proteins posses a "gain of function" phenotype. In the present study, we examined the effects of the second most frequent p53 mutant R273H on the p53REs of the MDM2, WAF1/Cip1 and Bax genes in the H1299 non-small cell lung carcinoma cell line. Although mt p53 R273H alone was unable to bind and transactivate the corresponding p53REs, it enhanced the MDM2-p53RE mediated gene transcription of wt p53 (positive-dominant effect) and prevented the wt p53 transactivation of the p53REs of WAF1/Cip1 and Bax genes (negative-dominant effect). Our data suggest that in the appropriate environment, differential transcription of critical p53 target genes by certain p53 mutant proteins may illustrate another mechanism implicated in tumor development.
Similar articles
- A novel p53 mutant retained functional activity in lung carcinomas.
Ko JL, Chiao MC, Chang SL, Lin P, Lin JC, Sheu GT, Lee H. Ko JL, et al. DNA Repair (Amst). 2002 Sep 4;1(9):755-62. doi: 10.1016/s1568-7864(02)00094-0. DNA Repair (Amst). 2002. PMID: 12509279 - Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
Bae I, Fan S, Bhatia K, Kohn KW, Fornace AJ Jr, O'Connor PM. Bae I, et al. Cancer Res. 1995 Jun 1;55(11):2387-93. Cancer Res. 1995. PMID: 7757991 - Effects of p53 mutants derived from lung carcinomas on the p53-responsive element (p53RE) of the MDM2 gene.
Gorgoulis VG, Zacharatos PV, Manolis E, Ikonomopoulos JA, Damalas A, Lamprinopoulos C, Rassidakis GZ, Zoumpourlis V, Kotsinas A, Rassidakis AN, Halazonetis TD, Kittas C. Gorgoulis VG, et al. Br J Cancer. 1998;77(3):374-84. doi: 10.1038/bjc.1998.60. Br J Cancer. 1998. PMID: 9472631 Free PMC article. - Mechanisms of p53-induced apoptosis: in search of genes which are regulated during p53-mediated cell death.
Choisy-Rossi C, Reisdorf P, Yonish-Rouach E. Choisy-Rossi C, et al. Toxicol Lett. 1998 Dec 28;102-103:491-6. doi: 10.1016/s0378-4274(98)00238-0. Toxicol Lett. 1998. PMID: 10022301 Review. - p53 in neuronal apoptosis.
Culmsee C, Mattson MP. Culmsee C, et al. Biochem Biophys Res Commun. 2005 Jun 10;331(3):761-77. doi: 10.1016/j.bbrc.2005.03.149. Biochem Biophys Res Commun. 2005. PMID: 15865932 Review.
Cited by
- NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF, Donninger H, Vos MD, Birrer MJ, Gordon L, Leaner V, Clark GJ. Calvisi DF, et al. Cancer Res. 2009 Jun 1;69(11):4629-37. doi: 10.1158/0008-5472.CAN-08-3672. Epub 2009 May 12. Cancer Res. 2009. PMID: 19435914 Free PMC article. - p53 activates ICAM-1 (CD54) expression in an NF-kappaB-independent manner.
Gorgoulis VG, Zacharatos P, Kotsinas A, Kletsas D, Mariatos G, Zoumpourlis V, Ryan KM, Kittas C, Papavassiliou AG. Gorgoulis VG, et al. EMBO J. 2003 Apr 1;22(7):1567-78. doi: 10.1093/emboj/cdg157. EMBO J. 2003. PMID: 12660163 Free PMC article. - ECRG2/SPINK7 Tumor Suppressor as Modulator of DNA Damage Response.
Patel H, Sheikh MS, Huang Y. Patel H, et al. Int J Mol Sci. 2024 May 28;25(11):5854. doi: 10.3390/ijms25115854. Int J Mol Sci. 2024. PMID: 38892042 Free PMC article. Review. - How many mutant p53 molecules are needed to inactivate a tetramer?
Chan WM, Siu WY, Lau A, Poon RY. Chan WM, et al. Mol Cell Biol. 2004 Apr;24(8):3536-51. doi: 10.1128/MCB.24.8.3536-3551.2004. Mol Cell Biol. 2004. PMID: 15060172 Free PMC article. - Involvement of p53 mutation and mismatch repair proteins dysregulation in NNK-induced malignant transformation of human bronchial epithelial cells.
Shen Y, Zhang S, Huang X, Chen K, Shen J, Wang Z. Shen Y, et al. Biomed Res Int. 2014;2014:920275. doi: 10.1155/2014/920275. Epub 2014 Aug 18. Biomed Res Int. 2014. PMID: 25215298 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous